Literature DB >> 24385653

The effect of case rate and coinfection rate on the positive predictive value of a registry data-matching algorithm.

Qiang Xia1, Sarah L Braunstein1, Laura E Stadelmann1, Preeti Pathela2, Lucia V Torian1.   

Abstract

OBJECTIVE: Statistical modeling has suggested that the prevalence of false matches in data matching declines as the events become rarer or the number of matches increases. We examined the effect of case rate and coinfection rate in the population on the positive predictive value (PPV) of a matching algorithm for HIV/AIDS and sexually transmitted disease (STD) surveillance registry data.
METHODS: We used LinkPlus™, a probabilistic data-matching program, to match HIV/AIDS cases diagnosed in New York City (NYC) from 1981 to March 31, 2012, and reported to the NYC HIV/AIDS surveillance registry against syphilis and chlamydia cases diagnosed in NYC from January 1 to June 30, 2010, and reported to the NYC STD registry. Match results were manually reviewed to determine true matches.
RESULTS: With an agreement/disagreement comparison score cutoff value of 10.0, LinkPlus identified 3,013 matches, of which 1,582 were determined to be true by manual review. PPV varied greatly in subpopulations with different case rates and coinfection rates. PPV was the highest (91.6%) in male syphilis cases, who had a relatively low case rate but a high HIV coinfection rate, and lowest (18.0%) in female chlamydia cases, who had a high case rate but a low HIV coinfection rate. When the cutoff value was increased to 15.0, PPVs in male syphilis and female chlamydia cases increased to 98.3% and 90.5%, respectively.
CONCLUSIONS: Case rates and coinfection rates have a significant effect on the PPV of a registry data-matching algorithm: PPV decreases as the case rate increases and coinfection rate decreases. Before conducting registry data matching, program staff should assess the case rate and coinfection rate of the population included in the data matching and select an appropriate matching algorithm.

Entities:  

Mesh:

Year:  2014        PMID: 24385653      PMCID: PMC3862993          DOI: 10.1177/00333549141291S112

Source DB:  PubMed          Journal:  Public Health Rep        ISSN: 0033-3549            Impact factor:   2.792


  10 in total

1.  HIV surveillance--United States, 1981-2008.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2011-06-03       Impact factor: 17.586

Review 2.  HIV prevalence in patients with syphilis, United States.

Authors:  M E Blocker; W C Levine; M E St Louis
Journal:  Sex Transm Dis       Date:  2000-01       Impact factor: 2.830

3.  High HIV seroprevalence associated with gonorrhea: New York City Department of Health, sexually transmitted disease clinics, 1990-1997.

Authors:  L V Torian; H A Makki; I B Menzies; C S Murrill; D A Benson; F W Schween; I B Weisfuse
Journal:  AIDS       Date:  2000-01-28       Impact factor: 4.177

4.  Estimating the sensitivity and specificity of matching name-based with non-name-based case registries.

Authors:  P Etkind; Y Tang; M Whelan; S Ratelle; J Murphy; S Sharnprapai; A Demaria
Journal:  Epidemiol Infect       Date:  2003-08       Impact factor: 2.451

5.  Co-occurrence of AIDS and tuberculosis: results of a database "match" and investigation.

Authors:  E L Gollub; R Trino; M Salmon; L Moore; J L Dean; B L Davidson
Journal:  J Acquir Immune Defic Syndr Hum Retrovirol       Date:  1997-09-01

6.  Matching AIDS and tuberculosis registry data to identify AIDS/tuberculosis comorbidity cases in California.

Authors:  Qiang Xia; Janice L Westenhouse; Alan F Schultz; Atsuko Nonoyama; William Elms; Nancy Wu; Lisette Tabshouri; Juan D Ruiz; Jennifer M Flood
Journal:  Health Informatics J       Date:  2011-03       Impact factor: 2.681

7.  HIV infection in men who have sex with men, New York City Department of Health sexually transmitted disease clinics, 1990-1999: a decade of serosurveillance finds that racial disparities and associations between HIV and gonorrhea persist.

Authors:  Lucia V Torian; Hadi A Makki; Isaura B Menzies; Christopher S Murrill; Isaac B Weisfuse
Journal:  Sex Transm Dis       Date:  2002-02       Impact factor: 2.830

8.  Cross-matching TB and AIDS registries: TB patients with HIV co-infection, United States, 1993-1994.

Authors:  M Moore; E McCray; I M Onorato
Journal:  Public Health Rep       Date:  1999 May-Jun       Impact factor: 2.792

9.  Incident sexually transmitted infections among persons living with diagnosed HIV/AIDS in New York City, 2001-2002: a population-based assessment.

Authors:  Susan E Manning; Melissa R Pfeiffer; Denis Nash; Susan Blank; Judith Sackoff; Julia Schillinger
Journal:  Sex Transm Dis       Date:  2007-12       Impact factor: 2.830

10.  Event-based record linkage in health and aged care services data: a methodological innovation.

Authors:  Rosemary Karmel; Diane Gibson
Journal:  BMC Health Serv Res       Date:  2007-09-25       Impact factor: 2.655

  10 in total
  3 in total

1.  Program collaboration and service integration in the prevention and control of HIV infection, viral hepatitis, STDs, and tuberculosis in the U.S.: lessons learned from the field.

Authors:  Kevin A Fenton; Gustavo A Aquino; Hazel D Dean
Journal:  Public Health Rep       Date:  2014 Jan-Feb       Impact factor: 2.792

2.  Undiagnosed HIV and HCV Infection in a New York City Emergency Department, 2015.

Authors:  Lucia V Torian; Uriel R Felsen; Qiang Xia; Fabienne Laraque; Eric J Rude; Herbert Rose; Adam Cole; Angelica Bocour; Gary J Williams; Robert F Bridgforth; Lisa A Forgione; Howard Doo; Sarah L Braunstein; Demetre C Daskalakis; Barry S Zingman
Journal:  Am J Public Health       Date:  2018-03-22       Impact factor: 9.308

3.  Diagnostic value of GeneChip for detection of resistant Mycobacterium tuberculosis in patients with differing treatment histories.

Authors:  Limei Zhu; Qiao Liu; Leonardo Martinez; Jinyan Shi; Cheng Chen; Yan Shao; Chongqiao Zhong; Honghuan Song; Guoli Li; Xiaoyan Ding; Yang Zhou; Linyang Zhu; Christopher C Whalen; Wei Lu
Journal:  J Clin Microbiol       Date:  2014-10-29       Impact factor: 5.948

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.